123986-64-1

Basic information

• Product Name: (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER
• Synonyms: 4-(BOC-AMINOMETHYL-PHENYL)-METHANOL;(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER;4-(N-TERT-BUTOXYCARBONYLAMINOMETHYL)BENZYL ALCOHOL;4-(N-tert-Butoxycarbonylaminomethyl)benzyl alcohol 97%;tert-BUTYL-4-(HYDROXYMETHYL)BENZYLCARBAMATE;(4-hydroxymethyl-benzyl)-carbamic acid ter-butyl ester;tert-Butyl [4-(hydroxymethyl)benzyl]carbamate 97%;4-(Aminomethyl)benzyl alcohol, N-BOC protected
• CAS NO: 123986-64-1
• Molecular Formula: C₁₃H₁₉NO₃
• Molecular Weight: 237.29
• Product Categories: Miscellaneous Biochemicals;Aminomethyl's;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het
• Mol File: 123986-64-1.mol
• Article Data: 37

Chemical Properties

• Melting Point: 98 °C
• Boiling Point: 397.2 °C at 760 mmHg
• Flash Point: 194 °C
• Appearance: /
• Density: 1.106 g/cm³
• Vapor Pressure: 5.08E-07mmHg at 25°C
• Refractive Index: 1.528
• Storage Temp.: 2-8°C
• PKA: 12.19±0.46(Predicted)
• CAS DataBase Reference: (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER(123986-64-1)
• EPA Substance Registry System: (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER(123986-64-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 123986-64-1(Hazardous Substances Data)

Usage

Description

(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound derived from benzyl carbamic acid, also known as a tert-butyl ester. It is commonly used in organic synthesis and pharmaceutical research due to its versatile properties and potential applications in various industries.

Uses

Used in Organic Synthesis:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a building block in organic synthesis for the creation of various compounds and materials. Its unique structure allows for the formation of new chemical bonds and the development of novel products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER serves as a key component in the synthesis of various drugs and pharmaceutical products. Its properties make it a valuable precursor for the development of new medications and therapeutic agents.
Used in Plastics Production:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a stabilizer in the production of plastics. Its presence helps to prevent the degradation of plastic materials, enhancing their durability and longevity.
Used in Coatings and Adhesives Manufacturing:
In the manufacturing of coatings and adhesives, (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER acts as a solvent. Its ability to dissolve other substances allows for the creation of effective coatings and adhesives with improved bonding and performance characteristics.
Used in the Development of New Materials:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER may also have potential applications in the development of new materials and compounds for various industrial and scientific purposes. Its unique properties and reactivity make it a promising candidate for further research and innovation.

InChI:InChI=1/C13H19NO3/c1-13(2,3)17-12(16)14-8-10-4-6-11(9-15)7-5-10/h4-7,15H,8-9H2,1-3H3,(H,14,16)

Upstream product

• 619-65-8 4-cyanobenzoic Acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1129-35-7 4-cyanobenzoic acid methyl ester 
• 105-07-7 4-cyanobenzaldehyde 
• 510772-10-8 4-(azidomethyl)benzaldehyde 
• 439691-96-0 [4-(azidomethyl)phenyl]methanol 
• 52010-97-6 4-(hydroxylmethyl)benzaldehyde 
• 51359-78-5 4-(bromomethyl)benzaldehyde 
• 81172-89-6 terephthalaldehyde mono(diethylacetal) 
• 125734-44-3 4-(hydroxymethyl)benzaldehyde diethyl acetal 
• 874-89-5 4-Cyanobenzyl alcohol 
• 33233-67-9 4-(tert-Butoxycarbonylaminomethyl)benzoic acid 
• 541-41-3 chloroformic acid ethyl ester 
• 6232-11-7 methyl 4-(aminomethyl)benzoate hydrochloride 

Downstream Products

• 156866-52-3 tert-butyl N-(4-formylbenzyl)carbamate 
• 1204738-53-3 1-[4-(4-aminomethyl-benzyloxy)-2-hydroxy-3-trifluoromethyl-phenyl]-2-methyl-propan-1-one hydrochloride 
• 34403-46-8 [4-(amino-methyl)phenyl]methanol hydrochloride 
• 442908-60-3 3-(4-aminomethylbenzyl)-7-(2-fluryl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine 
• 1439845-49-4 C₁₇H₂₅N₃O₄ 
• 1439853-60-7 methyl (E)-4-((4-(4-((tert-butoxycarbonylamino)methyl)benzylamino)butyl)(hydroxy)amino)-4-oxobut-2-enoate 
• 1439848-01-7 (E)-4-((4-(4-(aminomethyl)benzylamino)butyl)(hydroxy)amino)-4-oxobut-2-enoic acid 
• 1018674-43-5 cyclopentyl (2S)-cyclohexyl[(4-{[(3-{(1E)-3-[(1-isobutoxyethoxy)amino]-3-oxoprop-1-en-1-yl}benzyl)amino]methyl}benzyl)amino]acetate 

Relevant articles and documents

Supramolecular complexes obtained from porphyrin-crown ether conjugates and a fullerene derivative bearing an ammonium unit

A methanofullerene derivative with an ammonium subunit (1) has been prepared and its ability to form a supramolecular complex with a porphyrin-crown ether conjugate evidenced by NMR, UV-vis, electrospray mass spectrometry (ES-MS) and luminescence experime

Polymer-bound self-folding cavitands

The attachment of self-folding cavitands to polymeric supports has been succesfully demonstrated. Crosslinked polystyrene and PEGA were used. The synthesis of cavitands properly functionalized for this purpose is reported. The uptake of quest molecules by the resulting materials and the formation of inclusion complexes on the supports was demonstrated.

CHEMOKINE CXCR4 RECEPTOR MODULATORS AND USES RELATED THERETO

The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.

HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof. The compound has a superior TRPA1 antagonist activity, and can provide a medicament useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.